Industry Verticals »

All Categories

Insights »

About TMR »

Neurovascular Embolization Devices (Neurology) Market

Neurovascular Embolization Devices (Neurology) Market (Product: Embolization Coils, Liquid Embolic Systems, Flow Diversion Stents, Aneurysm Clips, and Others; Treatment: Ischemic Stroke Solutions and Hemorrhagic Stroke Solutions; Indication: Brain Aneurysms, Arteriovenous Malformation (AVM), and Others; and End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

WEB Devices Emerge as Less-invasive Alternative for Neurovascular Embolization Treatment

Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.

WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.

neurovascular embolization devices neurology market infographic

Healthcare Companies Scale Market Growth with Flow-diverting Devices

Recent advances in device technology are more focused on the control and precision of device placement during deployment procedures. To achieve this, healthcare companies in the neurovascular embolization devices (neurology) market are innovating in flow diversion technology. This is evident, as among the products in the neurovascular embolization devices (neurology) market, flow diversion stents are estimated to have the second-highest revenue of ~US$ 215 million by 2027.

Flow diversion technology has triggered the need for improved devices in the neurovascular embolization devices (neurology) landscape. As such, manufacturers are increasing the availability of flow-diverting devices for use in hospitals and ambulatory surgical centers. However, flow-diverting devices lead to challenging complications such as vertebrobasilar aneurysms in patients. Thus, healthcare companies are overcoming this limitation by seeking licensed approval from health commissions, so that their devices are credible. They are increasing research & development to validate clinically-approved data on the long-term benefits of using flow-diverting devices.

PED and Pipeline Flex: Reliable Treatment Options for Bifurcation Aneurysms

Although flow diversion stents result in fewer complications in patients, lack of clinical evidence about their long-term outcome remains a matter of debate. This is why, healthcare companies in the neurovascular embolization devices (neurology) market are supporting the treatment infrastructure with pipeline embolization devices (PEDs). Since these devices are outperforming other endoluminal devices, manufacturers are promoting their application for bifurcation aneurysms.

Posterior circulation aneurysm is another driver that is demanding the need for PEDs in the neurovascular embolization devices (neurology) market. As such, manufacturers are introducing variations in braided stents, local porosity, and filament position modeled with cone beam computed tomography to provide critical information to healthcare providers, prior to surgical treatments. PED technology is being rapidly transformed into pipeline flex technology. Although limited studies prove its long-term outcomes, pipeline flex is found to be a safe treatment option, and it serves as a short-term efficacy alternative.

neurovascular embolization devices neurology market segmentation

Analysts’ Viewpoint

The adoption of WEB devices for neurovascular embolization treatment is relatively slow in European countries. Thus, manufacturers in the neurovascular embolization devices (neurology) market should increase production capabilities for WEB devices in North America, since this region is projected to account for the largest market share in the neurovascular embolization devices (neurology) market over the forecast period.

Although embolization coils and flow diversion stents account for a significant amount of the revenue in the market, health complications associated with these products act as a hurdle for manufacturers. Taking a cue from the North America market, manufacturers in Europe and Asia Pacific should develop and promote WEB devices that will help create more incremental opportunities in these high-growth regions.

To gain credibility in the market, healthcare companies should seek approvals, such as the FDA Premarket Approval (PMA), to strategically market their product offerings in the highly consolidated global neurovascular embolization devices (neurology) market.

Neurovascular Embolization Devices (Neurology) Market: Overview

  • The global neurovascular embolization devices (neurology) market was valued at ~US$ 1.2 Bn in the years 2018, and the market is anticipated to reach ~US$ 1.6 Bn by 2027, expanding at a CAGR of ~3% from 2019 to 2027.
  • North America, Europe, and Asia Pacific were major markets for neurovascular embolization devices (neurology) in 2018. The neurovascular embolization devices (neurology) market in Asia Pacific is expected to expand at a higher CAGR of ~% during the forecast period, as compared to all other regions.
  • Stroke is a cerebrovascular accident caused due to blockage of blood supply to the brain cells. It is a sudden death of some brain cells, as oxygen supply is affected due to a ruptured artery or vein that supplies blood to these cells.
  • Increase in incidence of neurovascular diseases across the globe, rise in the prevalence of stroke, increasing elderly patient pool, and surge in the demand for procedures that are minimally-invasive are factors that are anticipated to drive the global neurovascular embolization devices (neurology) market during the forecast period of 2019 to 2027.

Neurovascular Embolization Devices (Neurology) Market: Segment Analysis

  • Based on product, the global neurovascular embolization devices (neurology) market has been segmented into liquid embolic systems, embolization coils, aneurysm clips, flow diversion stents, and others. The embolization coils segment accounted for a major share of the neurovascular embolization devices (neurology) market in 2018.
  • Increase in the demand for embolization coils, as they are preferred over other products for the treatment of cerebral aneurysms with strong clinical trial data is likely to boost the growth of the segment.
  • The development of embolization-enabling stents has extended the application base of embolic coiling for treatment of wide-neck bifurcation aneurysms. These factors are anticipated to propel the demand for neurovascular embolization devices (neurology) in the near future.
  • The flow diverter stents segment is expected to grow at a rapid pace during the forecast period. Strong growth of the segment can be attributed to the launch of Bravo Flow Diverter by Cerenovus in Europe in August 2018. The device is designed to divert blood flow from cerebral aneurysms, thereby reducing the risk of rupture. Moreover, flow-diversion stents exhibit an increased surface area, which directs a high volume of blood away from the aneurysm and eliminates the requirement of coiling.
  • In terms of treatment, the global neurovascular embolization devices (neurology) market has been segmented into ischemic stroke solutions and hemorrhagic stroke solutions. The hemorrhagic stroke solutions segment is anticipated to expand at a substantial CAGR between 2019 and 2027.
  • Increase in the prevalence of high blood pressure and brain aneurysms is a key factor that leads to hemorrhagic stroke. Furthermore, it is one of the most common emergencies encountered in clinical practice affecting the elderly population, which is anticipated to boost the growth of the segment in the near future.
  • On the basis of indication, the global neurovascular embolization devices (neurology) market has been categorized into brain aneurysm, arteriovenous malformations, and others. Surge in the number of cases of complex cerebral aneurysms across the world, and launch of novel neurovascular embolization devices (neurology) such as embolic stents and coils, are estimated to propel the segment during the forecast period.
  • Based on end user, the global neurovascular embolization devices (neurology) market is segmented into hospitals, ambulatory surgical centers, and specialty clinics. Hospitals accounted for a dominant share of the global neurovascular embolization devices (neurology) market in 2018, owing to a surge in the demand for minimally-invasive procedures for the treatment of stroke.
  • The availability of expert and skilled neurosurgeons and increase in the adoption of technologically-advanced devices in hospitals are other factors anticipated to boost the growth of the hospitals segment in the near future.

Neurovascular Embolization Devices (Neurology) Market: Key Insights

  • Coiling is a preferred mode of treatment for both, ruptured and unruptured brain aneurysms, which were initially treated by surgical clippings. Research studies have indicated that, the long-term success rate of coiling in brain aneurysms is over 85%.
  • The success rate of endovascular coiling for the treatment of cerebral aneurysms has led to a paradigm shift from clippings to coiling. All these factors are anticipated to drive the growth of the global neurovascular embolization devices (neurology) market in the coming years.
  • The launch of innovative embolization systems by industry players is anticipated to augment the global neurovascular embolization devices (neurology) market in the near future.
  • Developing economies such as India and China offer significant opportunities in the neurovascular embolization devices (neurology) market. Major factors include:
    • Rise in the prevalence and incidence rate of stroke in developing countries such as India and China, and growing geriatric patient pool, offer significant opportunities to market players to exploit these untapped markets. This is expected to drive the neurovascular embolization devices (neurology) market in the near future. For instance, approximately 15% of the China’s population was aged over 60 years in 2015, which is expected to increase to 36.5% by 2050.
  • All these factors provide several opportunities to players in the neurovascular embolization devices (neurology) market in these regions.

Neurovascular Embolization Devices (Neurology) Market: Prominent Players

  • Key players in the global neurovascular embolization devices (neurology) market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global neurovascular embolization devices (neurology) market report are
    • DePuy Synthes (Johnson & Johnson Services, Inc.)
    • Terumo Medical Corporation
    • Stryker Corporation
    • Boston Scientific Corporation
    • Penumbra, Inc.
    • Acandis GmbH
    • BALT EXTRUSION
    • Spartan Micro, Inc.
    • B. Braun Melsungen AG.

Frequently Asked Questions

What is the total market worth of neurovascular embolization devices (neurology) market?

Neurovascular embolization devices (neurology) market is anticipated to reach ~US$ 1.6 Bn by 2027

What is the anticipated CAGR of the neurovascular embolization devices (neurology) market in the forecast period?

Neurovascular embolization devices (neurology) market to expand at a CAGR of ~3% from 2019 to 2027

What are the key driving factors for the growth of the neurovascular embolization devices (neurology) market?

Neurovascular embolization devices (neurology) market is driven by increase in incidence of neurovascular diseases across the globe

Which is the rising prominent segment in the neurovascular embolization devices (neurology) market?

The embolization coils product segment dominated the global neurovascular embolization devices (neurology) market

Who are the key players in the neurovascular embolization devices (neurology) market?

Key players in the global neurovascular embolization devices (neurology) market include Stryker Corporation, Terumo Medical Corporation, DePuy Synthes (Johnson & Johnson Services, Inc.), Boston Scientific Corporation, Acandis GmbH

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Market Outlook

    5.1. Key Industry Developments 

    5.2. Regulatory Scenario

    5.3. Reimbursement Scenario

    5.4. Key Mergers & Acquisitions

    5.5. Technological Advancements

6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product 

    6.1. Introduction & Definition 

    6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        6.2.1. Embolization Coils

        6.2.2. Liquid Embolic Systems

        6.2.3. Flow Diversion Stents

        6.2.4. Aneurysm Clips

        6.2.5. Others

    6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product

7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment

    7.1. Introduction & Definition 

    7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        7.2.1. Ischemic Stroke Solution

        7.2.2. Hemorrhagic Stroke Solution

    7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment

8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication 

    8.1. Introduction 

    8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        8.2.1. Brain Aneurysms

        8.2.2. Arteriovenous Malformation (AVM)

        8.2.3. Others

    8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication

9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User

    9.1. Introduction 

    9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        9.2.1. Hospitals

        9.2.2. Ambulatory Surgery Centers

        9.2.3. Specialty Clinics

    9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User

10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region

    10.1. Introduction 

    10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027

        10.2.1. North America

        10.2.2. Europe

        10.2.3. Asia Pacific

        10.2.4. Latin America

        10.2.5. Middle East & Africa  

    10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region

11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

    11.1. Introduction

    11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        11.2.1. Embolization Coils

        11.2.2. Liquid Embolic Systems

        11.2.3. Flow Diversion Stents

        11.2.4. Aneurysm Clips

        11.2.5. Others

    11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        11.3.1. Ischemic Stroke Solution

        11.3.2. Hemorrhagic Stroke Solution

    11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        11.4.1. Brain Aneurysms

        11.4.2. Arteriovenous Malformation (AVM)

        11.4.3. Others

    11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        11.5.1. Hospitals

        11.5.2. Ambulatory Surgery Centers

        11.5.3. Specialty Clinics

    11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

        11.6.1. U.S.

        11.6.2. Canada

    11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

        11.7.1. By Product

        11.7.2. By Treatment 

        11.7.3. By Indication

        11.7.4. By End User

        11.7.5. By Country/Sub-region

12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

    12.1. Introduction

    12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        12.2.1. Embolization Coils

        12.2.2. Liquid Embolic Systems

        12.2.3. Flow Diversion Stents

        12.2.4. Aneurysm Clips

        12.2.5. Others

    12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        12.3.1. Ischemic Stroke Solution

        12.3.2. Hemorrhagic Stroke Solution

    12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        12.4.1. Brain Aneurysms

        12.4.2. Arteriovenous Malformation (AVM)

        12.4.3. Others

    12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        12.5.1. Hospitals

        12.5.2. Ambulatory Surgery Centers

        12.5.3. Specialty Clinics

    12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy 

        12.6.6. Rest of Europe

    12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

        12.7.1. By Product

        12.7.2. By Treatment 

        12.7.3. By Indication

        12.7.4. By End User

        12.7.5. By Country/Sub-region

13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

    13.1. Introduction

    13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        13.2.1. Embolization Coils

        13.2.2. Liquid Embolic Systems

        13.2.3. Flow Diversion Stents

        13.2.4. Aneurysm Clips

        13.2.5. Others

    13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        13.3.1. Ischemic Stroke Solution

        13.3.2. Hemorrhagic Stroke Solution

    13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        13.4.1. Brain Aneurysms

        13.4.2. Arteriovenous Malformation (AVM)

        13.4.3. Others

    13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        13.5.1. Hospitals

        13.5.2. Ambulatory Surgery Centers

        13.5.3. Specialty Clinics

    13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

        13.6.1. Japan

        13.6.2. China

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

        13.7.1. By Product

        13.7.2. By Treatment 

        13.7.3. By Indication

        13.7.4. By End User

        13.7.5. By Country/Sub-region

14. Latin America  Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

    14.1. Introduction

    14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        14.2.1. Embolization Coils

        14.2.2. Liquid Embolic Systems

        14.2.3. Flow Diversion Stents

        14.2.4. Aneurysm Clips

        14.2.5. Others

    14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        14.3.1. Ischemic Stroke Solution

        14.3.2. Hemorrhagic Stroke Solution

    14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        14.4.1. Brain Aneurysms

        14.4.2. Arteriovenous Malformation (AVM)

        14.4.3. Others

    14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        14.5.1. Hospitals

        14.5.2. Ambulatory Surgery Centers

        14.5.3. Specialty Clinics

    14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

        14.7.1. By Product

        14.7.2. By Treatment 

        14.7.3. By Indication

        14.7.4. By End User

        14.7.5. By Country/Sub-region

15. Middle East & Africa  Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast 

    15.1. Introduction

    15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027

        15.2.1. Embolization Coils

        15.2.2. Liquid Embolic Systems

        15.2.3. Flow Diversion Stents

        15.2.4. Aneurysm Clips

        15.2.5. Others

    15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027

        15.3.1. Ischemic Stroke Solution

        15.3.2. Hemorrhagic Stroke Solution

    15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027

        15.4.1. Brain Aneurysms

        15.4.2. Arteriovenous Malformation (AVM)

        15.4.3. Others

    15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027

        15.5.1. Hospitals

        15.5.2. Ambulatory Surgery Centers

        15.5.3. Specialty Clinics

    15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis

        15.7.1. By Product

        15.7.2. By Treatment 

        15.7.3. By Indication

        15.7.4. By End User

        15.7.5. By Country/Sub-region

16. Competition Landscape

    16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)

    16.2.  Company Profiles

        16.2.1. Medtronic plc

            16.2.1.1. Company Description

            16.2.1.2. Business Overview

            16.2.1.3. Financial Overview

            16.2.1.4. Strategic Overview

            16.2.1.5. SWOT Analysis

        16.2.2. Stryker Corporation

            16.2.2.1. Company Description

            16.2.2.2. Business Overview

            16.2.2.3. Financial Overview

            16.2.2.4. Strategic Overview

            16.2.2.5. SWOT Analysis

        16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.) 

            16.2.3.1. Company Description

            16.2.3.2. Business Overview

            16.2.3.3. Financial Overview

            16.2.3.4. Strategic Overview

            16.2.3.5. SWOT Analysis

        16.2.4. B.Braun Melsungen AG 

            16.2.4.1. Company Description

            16.2.4.2. Business Overview

            16.2.4.3. Financial Overview

            16.2.4.4. Strategic Overview

            16.2.4.5. SWOT Analysis

        16.2.5. Penumbra, Inc.

            16.2.5.1. Company Description

            16.2.5.2. Business Overview

            16.2.5.3. Financial Overview

            16.2.5.4. Strategic Overview

            16.2.5.5. SWOT Analysis

        16.2.6. Acandis GmbH

            16.2.6.1. Company Description

            16.2.6.2. Business Overview

            16.2.6.3. Financial Overview

            16.2.6.4. Strategic Overview

            16.2.6.5. SWOT Analysis

        16.2.7. BALT EXTRUSION

            16.2.7.1. Company Description

            16.2.7.2. Business Overview

            16.2.7.3. Financial Overview

            16.2.7.4. Strategic Overview

            16.2.7.5. SWOT Analysis

        16.2.8. Terumo Medical Corporation

            16.2.8.1. Company Description

            16.2.8.2. Business Overview

            16.2.8.3. Financial Overview

            16.2.8.4. Strategic Overview

            16.2.8.5. SWOT Analysis

        16.2.9. Boston Scientific Corporation

            16.2.9.1. Company Description

            16.2.9.2. Business Overview

            16.2.9.3. Financial Overview

            16.2.9.4. Strategic Overview

            16.2.9.5. SWOT Analysis

        16.2.10. Spartan Micro, Inc.

            16.2.10.1. Company Description

            16.2.10.2. Business Overview

            16.2.10.3. Financial Overview

            16.2.10.4. Strategic Overview

            16.2.10.5. SWOT Analysis

List of Tables

Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario 

Table 02: Physician Billing and Payment for Reimbursement

Table 03: Key Mergers and Acquisitions

Table 04: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 05: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017–2027

Table 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017–2027

Table 07: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017–2027

Table 08: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 10: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 12: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 13: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 14: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 16: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 17: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 18: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 19: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 20: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 21: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 22: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 23: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 24: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 25: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 26: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 27: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 28: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

Table 29: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 30: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 31: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027

Table 32: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027

Table 33: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027

List of Figures

Figure 01: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027

Figure 02: Neurovascular Embolization Devices (Neurology) Market – Key Industry Developments

Figure 03: Market Drivers 

Figure 04: Market Restraints

Figure 05: Key Opportunities

Figure 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, 2017–2027

Figure 07: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product (2018)

Figure 08: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment (2018)

Figure 09: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication (2018)

Figure 10: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User (2018)

Figure 11: Europe Regulatory Approval Process

Figure 12: Technological Advancements

Figure 13: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 14: Global Neurovascular Embolization Devices Neurology) Market Attractiveness, by Product, 2019–2027

Figure 15: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embolization Coils, 2017–2027

Figure 16: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liquid Embolic Systems, 2017–2027

Figure 17: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Diversion Stents, 2017–2027

Figure 18: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aneurysm Clips, 2017–2027

Figure 19: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 20: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 21: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 22: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke Solution, 2017–2027

Figure 23: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke Solution, 2017–2027

Figure 24: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 25: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 26: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Aneurysms, 2017–2027

Figure 27: Global Ne Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arteriovenous Malformations (AVMs), 2017–2027

Figure 28: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 29: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 30: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 31: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 32: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027

Figure 33: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

Figure 34: Global Neurovascular Embolization Devices (Neurology) Market: Regional Outlook

Figure 35: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Region, 2018 and 2027

Figure 36: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Region, 2019–2027

Figure 37: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 38: North America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country, 2018 and 2027

Figure 39: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country, 2019–2027

Figure 40: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 41: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 42: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 43: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 44: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 45: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 46: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 47: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 48: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 49: Europe Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 51: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 52: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 53: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 54: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 55: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 56: Europe N Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 57: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 58: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 59: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 60: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 61: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 62: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 63: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 64: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 65: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 66: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 67: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 68: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 69: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 70: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 71: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 72: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 73: Latin Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 74: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 75: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 76: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 77: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 78: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 79: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 80: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 81: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 82: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 83: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 84: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027

Figure 85: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027

Figure 86: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027

Figure 87: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027

Figure 88: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027

Figure 89: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027

Figure 90: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027

Figure 91: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027

Figure 92: Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018) 

Copyright © Transparency Market Research, Inc. All Rights reserved

Neurovascular Embolization Devices (Neurology) Market

Schedule a Call